Otofonix Encore vs Yeasound RIC800

The Otofonix Encore is a behind-the-ear prescription hearing aid priced at $295, placing it in the budget tier of the prescription category. In our lab testing, it earned a C grade with a SoundScore of 2.7/5, ranking 35th out of 36 prescription hearing aids tested. Sound performance presents significant challenges across most metrics. Speech clarity scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.32 and 0.96 points below category averages respectively. Music streaming capability is essentially absent at 0.0/5, and own-voice comfort is notably limited at 0.1/5 in the tuned configuration—2.65 points below the category average. The one bright spot is feedback handling, which scores an excellent 4.7/5. While this falls just 0.01 points below the category average, it represents strong absolute performance that should minimize whistling issues during daily use. This device runs on disposable batteries. At this price point, shoppers should be aware that the RxEars Rxi offers substantially better sound performance (4.09/5) in the same price range. The Otofonix Encore may suit budget-conscious consumers who prioritize feedback stability over speech clarity and streaming features, but our testing suggests most users would benefit from considering higher-performing alternatives within this price tier.

The Yeasound RIC800 is a mid-priced OTC hearing aid that earned an A grade with a SoundScore of 4.8/5 in our lab testing, placing it #2 among 65 OTC devices tested. At $659, this behind-the-ear rechargeable device delivers performance that significantly outpaces the category average of 3.71/5. Speech clarity is a standout strength. The RIC800 scores 4.4/5 for speech in quiet—a strong result that sits 1.63 points above the OTC category average. Speech in noise performance is more mixed at 2.4/5, though this still lands 0.93 points above the typical OTC device. Music streaming is where this device truly excels, scoring 4.3/5 and outperforming the category average by a substantial 2.38 points—making it one of the better choices for consumers who frequently stream audio from their phone. Feedback handling is excellent at 5.0/5, meaning users shouldn't encounter whistling issues during normal wear. The tradeoff comes with own-voice comfort, which scores 2.1/5—a mixed result that falls 0.41 points below the category average. Some users may notice their own voice sounds more hollow or boomy than expected. The RIC800 earned a 2025 Expert's Choice Award and supports both iPhone and Android streaming. For consumers seeking strong speech performance and exceptional streaming quality in the OTC space, this device represents a compelling option. Those particularly sensitive to own-voice quality may want to compare alternatives, but overall performance places the RIC800 among the top tier of OTC hearing aids we've tested.